Emergency Contraception - User's Profile

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Completed
CT.gov ID
NCT01771016
Collaborator
(none)
729
43

Study Details

Study Description

Brief Summary

Retrospective analysis of requests of emergency hormonal contraception using pharmacy protocols registered in 2003 and 2006.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In 2002, Levonorgestrel was introduced in Switzerland for emergency hormonal contraception (EC) without prescription ('pharmacist only'). In 2003, a first analysis of requests of EC showed that the dispensing of EC through pharmacies could successfully be implemented (Lemke et al 2004).

    This study was repeated three years later with the aim to explore whether the user's profile has changed after introduction of a low threshold access to EC.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    729 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Emergency Contraception - Observational Study of User's Profile
    Study Start Date :
    Jan 1, 2006
    Actual Primary Completion Date :
    Dec 1, 2008
    Actual Study Completion Date :
    Aug 1, 2009

    Outcome Measures

    Primary Outcome Measures

    1. Sexual and protective behaviour [2 years]

      questions of interest: "Did you forget to take the pill?", "Did you have any other unprotected sexual intercourse since your last period?" and "Have you ever taken the "morning-after pill" before?"

    Secondary Outcome Measures

    1. elapsed hours since unprotected intercourse [1 month]

    Other Outcome Measures

    1. pharmacy status and care activity [1 month]

      pharmacy status (walk-in or emergency), and the three activities of the pharmacists (performance of a pregnancy test, delivery of EHC, referral to a physician).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • women seaking emergency hormonal contraception
    Exclusion Criteria:

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University Hospital, Basel, Switzerland

    Investigators

    • Principal Investigator: Kurt E Hersberger, Prof., Dept Pharmaceutical Sciences, University Basel

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kurt Hersberger, Prof., University Hospital, Basel, Switzerland
    ClinicalTrials.gov Identifier:
    NCT01771016
    Other Study ID Numbers:
    • EKBB 114/07
    First Posted:
    Jan 18, 2013
    Last Update Posted:
    Jan 18, 2013
    Last Verified:
    Jan 1, 2013
    Keywords provided by Kurt Hersberger, Prof., University Hospital, Basel, Switzerland
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 18, 2013